EP3752494A1 - Reaktionen von olefinderivaten in gegenwart von metathesekatalysatoren - Google Patents

Reaktionen von olefinderivaten in gegenwart von metathesekatalysatoren

Info

Publication number
EP3752494A1
EP3752494A1 EP19705159.2A EP19705159A EP3752494A1 EP 3752494 A1 EP3752494 A1 EP 3752494A1 EP 19705159 A EP19705159 A EP 19705159A EP 3752494 A1 EP3752494 A1 EP 3752494A1
Authority
EP
European Patent Office
Prior art keywords
substituted
unsubstituted
hydrocarbyl
aryl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19705159.2A
Other languages
English (en)
French (fr)
Inventor
Richard L. Pederson
Adam M. Johns
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Umicore AG and Co KG
Original Assignee
Umicore AG and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Umicore AG and Co KG filed Critical Umicore AG and Co KG
Publication of EP3752494A1 publication Critical patent/EP3752494A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22—Organic complexes
    • B01J31/2265—Carbenes or carbynes, i.e.(image)
    • B01J31/2269—Heterocyclic carbenes
    • B01J31/2273—Heterocyclic carbenes with only nitrogen as heteroatomic ring members, e.g. 1,3-diarylimidazoline-2-ylidenes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22—Organic complexes
    • B01J31/2204—Organic complexes the ligands containing oxygen or sulfur as complexing atoms
    • B01J31/226—Sulfur, e.g. thiocarbamates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22—Organic complexes
    • B01J31/2265—Carbenes or carbynes, i.e.(image)
    • B01J31/2278—Complexes comprising two carbene ligands differing from each other, e.g. Grubbs second generation catalysts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/08—Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0046—Ruthenium compounds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/50—Redistribution or isomerisation reactions of C-C, C=C or C-C triple bonds
    • B01J2231/54—Metathesis reactions, e.g. olefin metathesis
    • B01J2231/543—Metathesis reactions, e.g. olefin metathesis alkene metathesis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80—Complexes comprising metals of Group VIII as the central metal
    • B01J2531/82—Metals of the platinum group
    • B01J2531/821—Ruthenium

Definitions

  • ruthenium metathesis catalysts have enabled the development of several research platforms including: ring opening metathesis polymerization (ROMP), ring opening cross metathesis (ROCM), cross metathesis (CM), ring closing metathesis (RCM).
  • ROMP ring opening metathesis polymerization
  • CCM cross metathesis
  • RCM ring closing metathesis
  • the invention provides methods for the synthesis of macrocyclic compounds utilized in the fragrance industry.
  • the odor of musk is perhaps the most universally appreciated fragrance.
  • the natural macrocyclic musk compounds turned out to be ketones (animal sources) and lactones (plant materials). They are 15- or l7-membered ring systems.
  • the type of odor is influenced by the ring size. Starting from 14 ring atoms, a weak musk scent is perceived. Compounds with 15- 16 ring atoms exhibit strong musk odor.
  • Macrocyclic musk compounds are expected to be of increasing importance in the future, especially because many of them are naturally occurring and even the synthetic representatives closely resemble the natural counterparts. In addition, the progress in synthetic chemistry contributes to declining prices and will stimulate increased use of this type of musk compounds.
  • Synthetic musk compounds can be divided into three major classes: aromatic nitro musk compounds, polycyclic musk compounds, and macrocyclic musk compounds. As such, macrocyclic musk compounds have increased in importance in recent years.
  • the present invention addresses the problems of the prior art and provides an efficient and high-yielding synthesis of macrocyclic musk compounds and their open-chain intermediates, utilizing cross metathesis reactions in the presence of Group 8 metal olefin metathesis catalysts.
  • Common macrocyclic musk compounds include ambrettolide (9-ambrettolide and
  • the invention provides a method of forming macrocyclic musk compounds comprising the steps of cross metathesizing a first olefin and a second olefin in the presence of at least one Group 8 metal olefin metathesis catalyst, to form a cross-metathesis product and then cyclizing the cross-metathesis product to form the desired macrocyclic musk compounds.
  • the macrocyclic musk compounds can be formed by ring closing metathesis of a diene, in the presence of at least one Group 8 metal olefin metathesis catalyst. More particularly the invention is concerned with novel methods for obtaining musk macrocycles in the Z configuration, via cross metathesis reactions, in the presence of at least one Group 8 metal Z- stereoretentive olefin metathesis catalyst.
  • the present invention relates to a process, involving ring closing metathesis in the presence of at least one Group 8 metal olefin metathesis catalyst, for preparing cyclic compounds having at least eight carbon atoms and at least one keto group, used in the fragrance industry.
  • the macrocyclic musk compounds can be synthesized via ring closing olefin metathesis reactions of bis-olefins in the presence of at least one Group 8 metal olefin metathesis catalyst.
  • the ring-closing metathesis reaction product has a carbon- carbon double bond in a Z-configuration and is represented by the structure of Formula (A):
  • q is 1 , 2, 3, or 4;
  • p 4, 5, 6, or 7.
  • the ring-closing metathesis reaction product has a carbon- carbon double bond in a Z-configuration and is represented by the structure of Formula (B):
  • r is 1, 2, 3, or 4;
  • v 4, 5, 6, or 7.
  • the ring-closing metathesis reaction product has a carbon- carbon double bond in a Z-configuration and is represented by the structure of Formula (C):
  • q c is 1, 2, 3, or 4;
  • p c 4, 5, 6, or 7.
  • the ring-closing metathesis reaction product has a carbon- carbon double bond and is represented by the structure of Formula (K):
  • x is 2, 3, 4 or 5;
  • y is 5, 6, 7, or 8.
  • the invention provides a method of forming a macrocyclic musk compound comprising the steps of cross metathesizing a first olefin and a second olefin in the presence of at least one Group 8 metal olefin metathesis catalyst, to form an
  • an olefin includes a single olefin as well as a combination or mixture of two or more olefins
  • reference to "a substituent” encompasses a single substituent as well as two or more substituents, and the like.
  • alkyl refers to a linear, branched, or cyclic saturated hydrocarbon group typically although not necessarily containing 1 to 30 carbon atoms, generally containing 1 to 24 carbon atoms, typically 1 to 12 carbon atoms, such as methyl, ethyl, «-propyl, /.v -propyl, «-butyl, /.v -butyl, /-butyl, octyl, decyl, and the like, as well as cycloalkyl groups such as cyclopentyl, cyclohexyl and the like.
  • lower alkyl intends an alkyl group of 1 to 6 carbon atoms
  • cycloalkyl intends a cyclic alkyl group, typically having 3 to 12, or 4 to 12, or 3 to 10, or 3 to 8, carbon atoms.
  • substituted alkyl refers to alkyl substituted with one or more substituent groups
  • heteroatom-containing alkyl and “heteroalkyl” refer to alkyl in which at least one carbon atom is replaced with a heteroatom. If not otherwise indicated, the terms “alkyl” and “lower alkyl” include linear, branched, cyclic, unsubstituted, substituted, and/or hetero atom-containing alkyl and lower alkyl, respectively.
  • alkylene refers to a divalent linear, branched, or cyclic alkyl group, where "alkyl” is as defined herein.
  • alkenyl refers to a linear, branched, or cyclic hydrocarbon group of 2 to 30 carbon atoms containing at least one double bond, such as ethenyl, «-propenyl, /.v -propcnyl, «-butenyl, /.v -butcnyl, octenyl, decenyl, tetradecenyl, hexadecenyl, eicosenyl, tetracosenyl, and the like.
  • alkenyl groups herein contain 2 to 24 carbon atoms
  • alkenyl herein contain 2 to 12 carbon atoms.
  • lower alkenyl intends an "alkenyl” group of 2 to 6 carbon atoms
  • cycloalkenyl intends a cyclic “alkenyl” group, typically having 5 to 8 carbon atoms.
  • substituted alkenyl refers to "alkenyl” substituted with one or more substituent groups
  • heteroatom- containing alkenyl and hctcroalkcnyl refer to "alkenyl” in which at least one carbon atom is replaced with a heteroatom.
  • alkenyl and lower alkenyl include linear, branched, cyclic, unsubstituted, substituted, and/or heteroatom-containing “alkenyl” and lower “alkenyl”, respectively.
  • alkenyl is used interchangeably with the term “olefin” herein.
  • alkenylene refers to a divalent linear, branched, or cyclic alkenyl group, where "alkenyl” is as defined herein.
  • alkynyl refers to a linear or branched hydrocarbon group of 2 to 30 carbon atoms containing at least one triple bond, such as ethynyl, «-propynyl, and the like.
  • alkynyl groups herein contain 2 to 24 carbon atoms; typical “alkynyl” groups described herein contain 2 to 12 carbon atoms.
  • lower alkynyl intends an "alkynyl” group of 2 to 6 carbon atoms.
  • substituted alkynyl refers to “alkynyl” substituted with one or more substituent groups
  • heteroatom-containing alkynyl and “hctcroalkynyl” refer to “alkynyl” in which at least one carbon atom is replaced with a heteroatom. If not otherwise indicated, the terms “alkynyl” and “lower alkynyl” include linear, branched, unsubstituted, substituted, and/or heteroatom-containing "alkynyl” and lower
  • alkoxy intends an alkyl group bound through a single, terminal ether linkage; that is, an "alkoxy” group can be represented as -O-alkyl where alkyl is as defined herein.
  • a "lower alkoxy” group intends an alkoxy group containing 1 to 6 carbon atoms.
  • alkenyloxy and lower alkenyloxy respectively refer to an alkenyl and lower alkenyl group bound through a single, terminal ether linkage
  • alkynyloxy and “lower alkynyloxy” respectively refer to an alkynyl and lower alkynyl group bound through a single, terminal ether linkage.
  • aryl refers to an aromatic substituent containing a single aromatic ring or multiple aromatic rings that are fused together, directly linked, or indirectly linked (such that the different aromatic rings are bound to a common group such as a methylene or ethylene moiety).
  • Aryl contain 5 to 30 carbon atoms, generally "aryl” groups contain 5 to 20 carbon atoms; and typically, “aryl” groups contain 5 to 14 carbon atoms.
  • Exemplary "aryl” groups contain one aromatic ring or two fused or linked aromatic rings, e.g., phenyl, naphthyl, biphenyl, diphenylether, diphenylamine, benzophenone, and the like.
  • Substituted aryl refers to an aryl moiety substituted with one or more substituent groups; for example, 2,4,6-trimethylphenyl (i.e., mesityl or Mes), 2-methyl-phenyl, 2,6-di-/.vo- propylphenyl (i.e., DIPP or DiPP), 2 -isopropyl-phenyl (i.e., IPP, Ipp or ipp), 2-/.so-propyl-6- methylphenyl (i.e., MIPP or Mipp or MiPP).
  • substituent groups for example, 2,4,6-trimethylphenyl (i.e., mesityl or Mes), 2-methyl-phenyl, 2,6-di-/.vo- propylphenyl (i.e., DIPP or DiPP), 2 -isopropyl-phenyl (i.e., IPP, Ipp or ipp), 2-/.so-propyl-6- methylpheny
  • aryloxy refers to an aryl group bound through a single, terminal ether linkage, wherein “aryl” is as defined herein.
  • An “aryloxy” group can be represented as -O-aryl where aryl is as defined herein.
  • Preferred “aryloxy” groups contain 5 to 24 carbon atoms, and particularly preferred “aryloxy” groups contain 5 to 14 carbon atoms.
  • aryloxy groups include, without limitation, phenoxy, o-halo-phenoxy, -halo- phcnoxy, -halo-phcnoxy, o-methoxy-phenoxy, w-mcthoxy-phcnoxy, -mcthoxy-phcnoxy, 2,4- dimethoxy-phenoxy, 3,4,5-trimethoxy-phenoxy, and the like.
  • alkaryl refers to an aryl group with an alkyl substituent
  • aralkyl refers to an alkyl group with an aryl substituent, wherein “aryl” and “alkyl” are as defined herein.
  • alkaryl and “aralkyl” groups contain 6 to 30 carbon atoms; generally,
  • alkaryl and “aralkyl” groups contain 6 to 20 carbon atoms; and typically, “alkaryl” and “aralkyl” groups contain 6 to 16 carbon atoms.
  • Alkaryl groups include, for example, p- methylphenyl, 2, 4-di methyl phenyl, / -cyclohcxyl phenyl, 2,7-dimethylnaphthyl, 7- cyclooctylnaphthyl, 3-ethyl-cyclopenta-l, 4-diene, and the like.
  • aralkyl groups include, without limitation, benzyl, 2-phenyl-ethyl, 3 -phenyl-propyl, 4-phenyl-butyl, 5 -phenyl- pentyl, 4-phenylcyclohexyl, 4-benzylcyclohexyl, 4-phenylcyclohexylmethyl, 4- benzylcyclohexylmethyl, and the like.
  • alkaryloxy and “aralkyloxy” refer to substituents of the formula -OR wherein R is “alkaryl” or “aralkyl”, respectively, as defined herein.
  • acyl refers to substituents having the formula -(CO)-alkyl, -(CO)-aryl, or -(CO)-aralkyl
  • acyloxy refers to substituents having the formula -0(CO)-alkyl, -0(CO)-aryl, or -0(CO)-aralkyl, wherein "alkyl,” “aryl, and “aralkyl” are as defined herein.
  • cyclic and “ring” refer to ali cyclic or aromatic groups that may or may not be substituted and/or heteroatom containing, and that can be monocyclic, bicyclic, or polycyclic.
  • alicyclic is used in the conventional sense to refer to an aliphatic cyclic moiety, as opposed to an aromatic cyclic moiety, and can be monocyclic, bicyclic, or polycyclic.
  • halo halogen
  • halide halogen
  • hydrocarbyl refers to univalent “hydrocarbyl” moieties containing 1 to
  • lower hydrocarbyl intends a "hydrocarbyl” group of 1 to 6 carbon atoms, typically 1 to 4 carbon atoms, and the term
  • hydrocarbylene intends a divalent’Tiydrocarbyl” moiety containing 1 to 30 carbon atoms, typically 1 to 24 carbon atoms, specifically 1 to 12 carbon atoms, including linear, branched, cyclic, saturated and unsaturated species.
  • lower hydrocarbylene intends a divalent’Tiydrocarbyl moiety containing 1 to 30 carbon atoms, typically 1 to 24 carbon atoms, specifically 1 to 12 carbon atoms, including linear, branched, cyclic, saturated and unsaturated species.
  • lower hydrocarbylene intends a
  • hydrocarbylene group of 1 to 6 carbon atoms.
  • substituted hydrocarbyl refers to
  • hydrocarbyl substituted with one or more substituent groups
  • heteroatom- containing hydrocarbyl and the terms “heterohydrocarbyl” refer to hydrocarbyl in which at least one carbon atom is replaced with a heteroatom.
  • substituted hydrocarbylene refers to "hydrocarbylene” substituted with one or more substituent groups
  • hydrocarbyl and hydrocarbylene are to be interpreted as including substituted and/or hetero atom-containing “hydrocarbyl” and “hydrocarbylene” moieties, respectively.
  • heteroatom-containing refers to a hydrocarbon molecule or a hydrocarbyl molecular fragment in which one or more carbon atoms is replaced with an atom other than carbon, e.g., nitrogen, oxygen, sulfur, phosphorus or silicon, typically nitrogen, oxygen or sulfur.
  • heteroalkyl refers to an alkyl substituent that is hetero atom-containing
  • heterocyclic refers to a cyclic substituent that is heteroatom-containing
  • heteroaryl refers to a cyclic substituent that is heteroatom-containing
  • heteroaryl and heteroaromatic respectively refer to “aryl” and “aromatic” substituents that are heteroatom-containing, and the like.
  • a “heterocyclic” group or compound may or may not be aromatic, and further that “heterocycles” can be monocyclic, bicyclic, or polycyclic as described herein with respect to the term "aryl.” Examples of heteroalkyl groups include alkoxyaryl,
  • heteroaryl substituents include pyrrolyl, pyrrolidinyl, pyridinyl, quinolinyl, indolyl, pyrimidinyl, imidazolyl, 1 ,2,4-triazolyl, tetrazolyl, etc.
  • substituted as in “substituted hydrocarbyl,” “substituted alkyl,” “substituted aryl,” and the like, as alluded to in some of the aforementioned definitions, is meant that in the hydrocarbyl, alkyl, aryl, or other moiety, at least one hydrogen atom bound to a carbon (or other) atom is replaced with one or more non-hydrogen substituents.
  • substituents include, without limitation: functional groups referred to herein as "Fn,” such as halo, hydroxyl, sulfhydryl, C1-C24 alkoxy, C2-C24 alkenyloxy, C2-C24 alkynyloxy, C5-C24 aryloxy, C6-C24 aralkyloxy, C 6 -C 24 alkaryloxy, acyl (including C 2 -C 24 alkylcarbonyl (-CO-alkyl) and C 6 -C 24 arylcarbonyl (-CO-aryl)), acyloxy (-O-acyl, including C 2 -C 24 alkylcarbonyloxy (-O-CO-alkyl) and C6-C24 arylcarbonyloxy (-O-CO-aryl)), C2-C24 alkoxycarbonyl (-(CO)-O-alkyl), C6-C24 aryloxycarbonyl (-(CO)-aryl), hal
  • N-hetero cyclic carbene ligand refers to a N-hetero cyclic carbene ligand.
  • CAAC cyclic alkyl amino carbene ligand also known as " Bertrand-type ligand”.
  • Functional groups such as ether, ester, hydroxyl, carbonate
  • any of the protecting groups commonly used in the art may be employed.
  • Acceptable protecting groups may be found, for example, in Greene et al., Protective Groups in Organic Synthesis, 4rd Ed. (Published by John Wiley & Sons, Inc., Hoboken, New Jersey 2007).
  • the geometry of the olefins described in this patent application may be of E- configuration, or of Z-configuration, or of a mixture of E- and Z-configurations.
  • Applicants have represented a mixture of double-bond isomers by using a squiggly bond For example, as
  • structure R a exemplifies either the E- configuration
  • Suitable ether protecting groups include a branched or non-branched alkyl moiety containing 1 to 5 carbon atoms, for example methyl, ethyl, propyl, i-propyl, t-Bu or t-amyl.
  • Suitable silyl ether protecting groups include -Si(R) 3 ; wherein R is a branched or unbranched alkyl moiety, which may include methyl, ethyl and propyl and t-butyl.
  • Suitable carbonate protecting groups include -C(0)OR, wherein R is a branched or non-branched alkyl moiety, for example methyl, ethyl or propyl.
  • sulfoxide group is meant -[S(O)]-.
  • “functionalized olefin,” “functionalized cyclic olefin,” and the like, is meant that in the hydrocarbyl, alkyl, olefin, cyclic olefin, or other moiety, at least one hydrogen atom bound to a carbon (or other) atom is replaced with one or more functional groups such as those described herein.
  • the term “functional group” is meant to include any functional species that is suitable for the uses described herein. In particular, as used herein, a functional group would necessarily possess the ability to react with or bond to corresponding functional groups on a substrate surface.
  • the functional groups may, if a particular group permits, be further substituted with one or more additional functional groups or with one or more hydrocarbyl moieties such as those specifically enumerated herein.
  • the herein-mentioned hydrocarbyl moieties can be further substituted with one or more functional groups or additional hydrocarbyl moieties such as those specifically enumerated.
  • the Group 8 metal olefin metathesis catalysts of the invention are represented by the general structure of Formula (1)
  • M is a Group 8 transition metal; generally, M is ruthenium or osmium; typically,
  • M is ruthenium
  • L 1 and L 2 are independently neutral electron donor ligands
  • n is 0 or 1 ; typically, n is 0;
  • n 0, 1 or 2; typically, m is 0;
  • R a is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted hetero atom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R a is unsubstituted Ci-Cio alkyl, substituted Ci-Cio alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically, R a is methyl, ethyl, «-propyl, /.v -propyl, «-butyl, /er/-butyl, cyclohexyl or phenyl;
  • R b is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted hetero atom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally R b is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically R b is methyl, ethyl, «-propyl, wo-propyl, «-butyl, tert- butyl, cyclohexyl or phenyl; or R a and R b are linked together to form a five or a six heterocyclic membered ring with the sulfoxide group [- S(O)-];
  • X 1 and X 2 are independently anionic ligands; generally, X 1 and X 2 are independently halogen, trifluoroacetate, per-fluorophenols or nitrate; typically, X 1 and X 2 are independently Cl, Br, I or F; and
  • R 1 and R 2 are independently hydrogen, unsubstituted hydrocarbyl, substituted
  • hydrocarbyl unsubstituted heteroatom-containing hydrocarbyl, or substituted
  • R 1 is hydrogen and R 2 is unsubstituted phenyl, substituted phenyl, Ci-C 6 alkyl or substituted 1 -propenyl; or R 1 and R 2 are linked together to form an optionally substituted indenylidene.
  • X 3 and X 4 are independently O or S;
  • R x , R y , R w and R z are independently hydrogen, halogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted hetero atom-containing hydrocarbyl; or R x and R y are linked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl; or R w and R z are linked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl; or R y and R w are linked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl.
  • the Group 8 metal olefin metathesis catalysts used in the invention can be represented by the structure of Formula (2):
  • M is a Group 8 transition metal; generally, M is ruthenium or osmium; typically,
  • M is ruthenium
  • L 1 and L 2 are independently a neutral electron donor ligand
  • n is 0 or 1 ; typically, n is 0;
  • n 0, 1 or 2; typically, m is 0;
  • R a is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted hetero atom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R a is unsubstituted Ci-Cio alkyl, substituted Ci-Cio alkyl, unsubstituted C 3 -C 10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically, R a is methyl, ethyl, «-propyl, /.v -propyl, «-butyl, / ⁇ 2/7-butyl, cyclohexyl or phenyl;
  • R b is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted hetero atom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally R b is unsubstituted C 1 -C 10 alkyl, substituted C 1 -C 10 alkyl, unsubstituted C 3 -C 10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically R b is methyl, ethyl, «-propyl, wo-propyl, «-butyl, tert- butyl, cyclohexyl or phenyl; or R a and R b are linked together to form a five or a six heterocyclic membered ring with the sulfoxide group;
  • R 1 and R 2 are independently hydrogen, unsubstituted hydrocarbyl, substituted
  • hydrocarbyl unsubstituted heteroatom-containing hydrocarbyl, or substituted
  • hetero atom-containing hydrocarbyl typically, R 1 is hydrogen and R 2 is unsubstituted
  • R 1 and R 2 are linked together to form an optionally substituted indenylidene
  • X 3 and X 4 are independently O or S; typically, X 3 and X 4 are independently S;
  • R x , R y , R w and R z are independently hydrogen, halogen, unsubstituted
  • R x , R y , R w and R z are
  • R x , R y , R w and R z are independently Ci-C 6 alkyl,
  • R x and R y are linked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl; or R w and R z are linked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl; or R y and R w are linked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl.
  • the Group 8 metal olefin metathesis catalysts used in the invention are represented by the structure of Formula (3),
  • M is a Group 8 transition metal; generally, M is ruthenium or osmium; typically, M is ruthenium;
  • L 2 is a neutral electron donor ligand
  • n is 0 or 1 ; typically, n is 0;
  • n 0, 1 or 2; typically, m is 0;
  • R a is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted hetero atom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R a is unsubstituted Ci-Cio alkyl, substituted Ci-Cio alkyl, unsubstituted C 3 -C 10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically, R a is methyl, ethyl, «-propyl, wo-propyl, «-butyl, / ⁇ v7-butyl, cyclohexyl or phenyl;
  • R b is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted hetero atom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally R b is unsubstituted C 1 -C 10 alkyl, substituted C 1 -C 10 alkyl, unsubstituted C 3 -C 10 cycloalkyl, substituted C 3 -C 10 cycloalkyl, unsubstituted C 5 -C 24 aryl or substituted C 5 -C 24 aryl; typically R b is methyl, ethyl, «-propyl, wo-propyl, «-butyl, / ⁇ v7-butyl, cyclohexyl or phenyl; or R a and R b are linked together to form a five or a six heterocyclic membered ring with the sulfoxide group; X 1 and X 2 are independently anionic lig
  • R 1 and R 2 are independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted
  • hetero atom-containing hydrocarbyl typically, R 1 is hydrogen and R 2 is unsubstituted
  • R 1 and R 2 are linked together to form an optionally substituted indenylidene
  • X 5 and Y 5 are independently C, CR 3A , N, O, S, or P; only one of X 5 or Y 5 can be C or CR 3A ; typically, X 5 and Y 5 are independently N;
  • Q 1 , Q 2 , R 3 , R 3A and R 4 are independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted hetero atom-containing hydrocarbyl; generally, Q 1 , Q 2 , R 3 , R 3A and R 4 are optionally
  • linker such as unsubstituted hydro carbylene, substituted
  • hydrocarbylene unsubstituted heteroatom-containing hydrocarbylene, substituted
  • hetero atom-containing hydrocarbylene or -(CO)-; typically Q 1 , Q 2 , R 3 , R 3A and R 4 are directly linked to X 5 or Y 5 ; and
  • p is 0 when X 5 is O or S, p is 1 when X 5 is N, P or CR 3A , and p is 2 when X 5 is C; q is 0 when Y 5 is O or S, q is 1 when Y 5 is N, P or CR 3A , and q is 2 when X 5 is C.
  • the Group 8 metal olefin metathesis catalysts used in the invention are represented by the structure of Formula (4):
  • M is a Group 8 transition metal; generally, M is ruthenium or osmium; typically, M is ruthenium;
  • n is 0 or 1 ; typically, n is 0;
  • n 0, 1 or 2; typically, m is 0;
  • R a is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted hetero atom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R a is unsubstituted Ci-Cio alkyl, substituted Ci-Cio alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically, R a is methyl, ethyl, «-propyl, /.v -propyl, «-butyl, / ⁇ 2/ 7-butyl, cyclohexyl or phenyl;
  • R b is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted hetero atom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R b is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically, R b is methyl, ethyl, «-propyl, wo-propyl, «-butyl, / ⁇ 2/ 7-butyl, cyclohexyl or phenyl;
  • R a and R b are linked together to form a five or a six-heterocyclic membered ring with the sulfoxide group;
  • X 1 and X 2 are independently anionic ligands; generally, X 1 and X 2 are independently halogen, trifluoroacetate, per-fluorophenols or nitrate; typically, X 1 and X 2 are independently Cl, Br, I or F;
  • R 1 and R 2 are independently hydrogen, unsubstituted hydrocarbyl, substituted
  • hydrocarbyl unsubstituted heteroatom-containing hydrocarbyl, or substituted heteroatom- containing hydrocarbyl; typically, R 1 is hydrogen and R 2 is unsubstituted phenyl, substituted phenyl, Ci-C 6 alkyl or substituted l-propenyl; or R 1 and R 2 are linked together to form an optionally substituted indenylidene;
  • X 5 and Y 5 are independently C, CR 3A , or N; only one of X 5 or Y 5 can be C or CR 3A ; typically, X 5 and Y 5 are independently N;
  • R 3A is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted hetero atom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl;
  • s and "t” are independently 1 or 2; typically, “s” and “t” are independently 1 ; or any two of R 11 , R 12 , R 13 , and R 14 are optionally linked together to form a substituted or unsubstituted, saturated or unsaturated ring structure;
  • R 3 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted
  • hetero atom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl
  • R 3 is unsubstituted C3 C 10 cycloalkyl, substituted C3-C10 cycloalkyl,
  • C5-C24 aryl unsubstituted (C5-C24 aryl), (C5-C24 aryl) substituted with up to three substituents selected from unsubstituted C1-C20 alkyl, substituted C1-C20 alkyl, unsubstituted C1-C20
  • heteroalkyl substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 hetero aryl, substituted C5-C24 hetero aryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 alkaryl, substituted C6-C24
  • R 3 is adamantyl, 2,4,6-trimethylphenyl, 2,6-di-/.vo- propylphenyl, 2-methyl-6-/er/-butylphenyl, 2 -iso -propyl-6 -methylphenyl, 2-/.vo-propyl- phenyl, 2,6-di-ethylphenyl, 2-ethyl-6-methylphenyl, 2,4,6-trifluorophenyl, 3,5-di-/ ⁇ 2/ 7- butylphenyl, 2,4-dimethylphenyl, 2,6-difluorophenyl, 2-fluoro-6-methylphenyl or 2- methyl-phenyl; and
  • R 4 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted
  • hetero atom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl
  • R 4 is unsubstituted C 3 C 10 cycloalkyl, substituted C 3- C 10 cycloalkyl,
  • R 4 is , 2,4,6-trimethylphenyl, 2 , 6 - d i - is -propylphcnyl, 2-methyl-6- /er/-butylphenyl, 2-/.v -propyl-6-mcthyl phen
  • X 1 , X 2 , X 3 , X 4 , M, R x , R y , R and R z are as defined herein.
  • R 1 is hydrogen
  • R 2 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom- containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; typically, R 2 is unsubstituted phenyl, substituted phenyl, Ci-C 6 alkyl or substituted l-propenyl; or R 1 and R 2 are linked together to form an optionally substituted indenylidene;
  • R a is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted hetero atom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R a is unsubstituted C 1 -C 10 alkyl, substituted C 1 -C 10 alkyl, unsubstituted C 3 -C 10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically, R a is methyl, ethyl, «-propyl, /.v -propyl, «-butyl, /er/-butyl, cyclohexyl or phenyl;
  • R b is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted hetero atom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally R b is unsubstituted C 1 -C 10 alkyl, substituted C 1 -C 10 alkyl, unsubstituted C 3 -C 10 cycloalkyl, substituted C 3 -C 10 cycloalkyl, unsubstituted C 5 -C 24 aryl or substituted C 5 -C 24 aryl; typically R b is methyl, ethyl, «-propyl, wo-propyl, «-butyl, tert- butyl, cyclohexyl or phenyl; or R a and R b are linked together to form a five or a six heterocyclic membered ring with the sulfoxide group; typically, R a and R b are linked together to form a
  • X 1 and X 2 are independently halogen, trifluoroacetate, per-fluorophenols or nitrate;
  • X 1 and X 2 are independently Cl, Br, I or F; typically, X 1 and X 2 are independently Cl;
  • R 3 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted
  • hetero atom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl
  • R 3 is unsubstituted C 3 C 10 cycloalkyl, substituted C 3- C 10 cycloalkyl,
  • hetero alkyl substituted C 1 -C 20 heteroalkyl, unsubstituted C 5 -C 24 aryl, substituted C 5 -C 24 aryl, unsubstituted C 5 -C 24 hetero aryl, substituted C 5 -C 24 hetero aryl, unsubstituted C 6 -C 24 aralkyl, substituted C 6 -C 24 aralkyl, unsubstituted C 6 -C 24 alkaryl, substituted C 6 -C 24
  • R 3 is adamantyl, 2,4,6-trimethylphenyl, 2,6-di-/.vo- propylphenyl, 2-/.v -propyl-6-mcthylphcnyl, 2-/.vo-propyl-phcnyl or 2-methyl-phenyl;
  • R 4 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted
  • hetero atom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl
  • R 4 is unsubstituted C 3 C 10 cycloalkyl, substituted C 3- C 10 cycloalkyl,
  • R 4 is 2,4,6- trimethylphenyl, 2-/.v -propyl-phcnyl, 2,6-di-/s
  • Non-limiting examples of olefin metathesis catalysts represented by the structure of Formula (5) are described in Table (1), wherein X 1 is Cl and X 2 is Cl.
  • R 13 are hydrogen, and M is ruthenium, then the olefin metathesis catalyst of Formula (4), is represented by the structure of Formula (6)
  • R 1 is hydrogen
  • R 2 is unsubstituted phenyl, substituted phenyl, Ci-C 6 alkyl or substituted l-propenyl; or R 1 and R 2 are linked together to form an optionally substituted indenylidene;
  • R a is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted hetero atom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl;
  • R a is unsubstituted C 1 -C 10 alkyl, substituted C 1 -C 10 alkyl, unsubstituted C 3 -C 10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl;
  • R b is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted hetero atom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl;
  • R b is unsubstituted C 1 -C 10 alkyl, substituted Ci-C 10 alkyl, unsubstituted C 3 -C 10 cycloalkyl, substituted C 3 -C 10 cycloalkyl, unsubstituted C 5 -C 24 aryl or substituted C 5 -C 24 aryl; or
  • R a and R b are linked together to form a five or a six-heterocyclic membered ring with the sulfoxide group;
  • X 1 and X 2 are independently halogen, trifluoroacetate, per-fluorophenols or
  • X 1 and X 2 are independently Cl, Br, I or F; typically, X 1 and X 2 are independently Cl;
  • R 3 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted
  • hetero atom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl
  • R 3 is unsubstituted C 3 C 10 cycloalkyl, substituted C 3- C 10 cycloalkyl,
  • heteroalkyl substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C 5 -C 24 hetero aryl, substituted C 5 -C 24 hetero aryl, unsubstituted C 6 -C 24 aralkyl, substituted C 6 -C 24 aralkyl, unsubstituted C 6 -C 24 alkaryl, substituted C 6 -C 24
  • R 3 is adamantyl, 2,4,6-trimethylphenyl, 2,6-di-/.vo- propylphenyl, 2-/so-propyl-6-methylphenyl, 2-/.vo-propyl-phcnyl or 2-methyl-phenyl;
  • R 4 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted
  • hetero atom-containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl
  • R 4 is unsubstituted C 3 C 10 cycloalkyl, substituted C 3- C 10 cycloalkyl,
  • R 4 is 2,4,6-trimethylphenyl, 2 - iso - p ro py 1 - p h c n y 1 , 2,6-di-/.v - propylphenyl, 2 -iso -propyl-6 -methylphenyl or 2 -methyl-phenyl.
  • Non-limiting examples of olefin metathesis catalysts represented by the structure of Formula (6) are described in Table (2), wherein X 1 is Cl and X 2 is Cl.
  • R 1 is hydrogen
  • R 2 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom- containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R 2 is unsubstituted phenyl, substituted phenyl, Ci-C 6 alkyl or substituted l-propenyl; or R 1 and R 2 are linked together to form an optionally substituted indenylidene;
  • R a is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted hetero atom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally, R a is unsubstituted Ci-Cio alkyl, substituted Ci-Cio alkyl, unsubstituted C 3 -C 10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically, R a is methyl, ethyl, «-propyl, /.v -propyl, «-butyl, / ⁇ 2/7-butyl, cyclohexyl or phenyl;
  • R b is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted hetero atom-containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally R b is unsubstituted C 1 -C 10 alkyl, substituted C 1 -C 10 alkyl, unsubstituted C 3 -C 10 cycloalkyl, substituted C3-C10 cycloalkyl, unsubstituted C5-C24 aryl or substituted C5-C24 aryl; typically R b is methyl, ethyl, «-propyl, /.v -propyl, «-butyl, /er/-butyl, cyclohexyl or phenyl; or R a and R b are linked together to form a five or a six heterocyclic membered ring with the sulfoxide group;
  • X 1 and X 2 are independently halogen, trifluoroacetate, per-fluorophenols or nitrate; generally, X 1 and X 2 are independently Cl, Br, I or F; typically, X 1 and X 2 are independently Cl;
  • R 3 is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted
  • heteroatom containing hydrocarbyl or substituted heteroatom-containing hydrocarbyl
  • R 3 is unsubstituted C3 C 10 cycloalkyl, substituted C3-C10 cycloalkyl,
  • hetero alkyl substituted C1-C20 heteroalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 hetero aryl, substituted C5-C24 hetero aryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 alkaryl, substituted C6-C24
  • R 3 is adamantyl, 2,4,6-trimethylphenyl, 2,6-di-/.vo- propylphenyl, 2-methyl-6-/er/-butylphenyl, 2 -iso -propyl-6 -methylphenyl, 2-/.vo-propyl- phenyl, 2,6-di-ethylphenyl, 2-ethyl-6-methylphenyl or 2-methyl-phenyl;
  • R 11 , R 12 , R 13 and R 14 are independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted hetero atom-containing hydrocarbyl; generally, R 11 , R 12 , R 13 and R 14 are independently hydrogen, unsubstituted C1-C12 alkyl, substituted C1-C12 alkyl, unsubstituted C4-C12
  • R 11 and R 12 are independently methyl and R 13 and R 14 are independently hydrogen;
  • R 3A is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl,
  • R 3A is unsubstituted C 1 -C 12 alkyl, substituted C 1 -C 12 alkyl,
  • R 3A is methyl, ethyl, «-propyl, or phenyl; or R 3A together with R 4 can form a five to ten membered cycloalkyl or heterocyclic ring, with the carbon atom to which they are attached;
  • R 4 is hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted hetero atom-containing hydrocarbyl, or substituted hetero atom-containing hydrocarbyl; generally, R 4 is unsubstituted C1-C12 alkyl, substituted C1-C12 alkyl, unsubstituted C4-C12 cycloalkyl, substituted C4-C12 cycloalkyl, unsubstituted C5-C24 aryl, substituted C5-C24 aryl, unsubstituted C5-C24 heteroaryl, substituted C5-C24 heteroaryl, unsubstituted C6-C24 aralkyl, substituted C6-C24 aralkyl, unsubstituted C6-C24 heteroaralkyl or substituted C6-C24 heteroaralkyl; typically R 4 is methyl, ethyl, «-propyl, or phenyl.
  • Non-limiting examples of olefin metathesis catalysts represented by the structure of Formula (7) are described in Table (3), wherein X 1 is Cl, X 2 is Cl, R 11 is methyl, R 12 is methyl, R 13 is hydrogen and R 14 is hydrogen.
  • L 1 is a CAAC ligand of formula:
  • X is -CR la R 2a -;
  • a is 1 or 2;
  • R la is H, optionally substituted Ci -24 alkyl, optionally substituted C 3-10 cycloalkyl, halogen, optionally substituted C 5 -C 24 aryl, optionally substituted C 6 -C 24 aralkyl, optionally substituted C1-C20 heteroalkyl, - C(0)R 21 , - OR 22 , CN, - NR 23 R 24 , NO2, -CF3, -S(0) x R 25 , - P(0)(0H) 2 , -0P(0)(0H) 2 , -SR 27 , or together with R 2a forms an optionally substituted spiro monocyclic or spiro polycyclic C 3-10 cycloalkyl or spiro heterocyclic ring, with the carbon atom to which they are attached, or together with R 3 or together with R 4 forms an optionally substituted polycyclic ring;
  • R 2a is H, optionally substituted Ci- 24 alkyl, optionally substituted C 3-10 cycloalkyl, halogen, optionally substituted C 5 -C 24 aryl, optionally substituted C 6 -C 24 aralkyl, optionally substituted C 1 -C 20 heteroalkyl, - C(0)R 21 , - OR 22 , CN, - NR 23 R 24 , N0 2 , -CF 3 , -S(0) x R 25 , - P(0)(0H) 2 , -0P(0)(0H) 2 , -SR 27 , or together with R la forms a spiro monocyclic or spiro polycyclic C 3-10 cycloalkyl or spiro heterocyclic ring, with the carbon atom to which they are attached, or together with R 3 or together with R 4 forms an optionally substituted polycyclic ring;
  • Y is -CR lb R 2b -;
  • b 0, 1 or 2;
  • R lb is H, optionally substituted Ci-24 alkyl, optionally substituted C3-10 cycloalkyl, halogen, optionally substituted C5-C24 aryl, optionally substituted C6-C24 aralkyl, optionally substituted C1-C20 heteroalkyl, - C(0)R 21 , - OR 22 , CN, - NR 23 R 24 , N0 2 , -CF 3 , -S(0) x R 25 , - P(0)(0H) 2 , -0P(0)(0H) 2 , -SR 27 , or together with R 2b forms a five-, six-, or ten-membered cycloalkyl or heterocyclic ring, with the carbon atom to which they are attached;
  • R 2b is H, optionally substituted Ci-24 alkyl, optionally substituted C3-10 cycloalkyl, halogen, optionally substituted C5-C24 aryl, optionally substituted C6-C24 aralkyl, optionally substituted C1-C20 heteroalkyl, - C(0)R 21 , - OR 22 , CN, - NR 23 R 24 , N0 2 , -CF 3 , -S(0) x R 25 , - P(0)(0H) 2 , -0P(0)(0H) 2 , -SR 27 , or together with R lb forms a five-, six-, or ten-membered cycloalkyl or heterocyclic ring, with the carbon atom to which they are attached;
  • R 3a is H, optionally substituted Ci-24 alkyl, halogen, - C(0)R 21 , - OR 22 , CN, - NR 23 R 24 , NO2, -CF 3 , -S(0) X R 25 , -P(0)(0H) 2 , -0P(0)(0H) 2 , -SR 27 , optionally substituted heterocycle, optionally substituted C 3-i o cycloalkyl, optionally substituted C5-24 aryl, optionally substituted C 3- 8 cycloalkenyl, or together with R la or together with R 2a can form an optionally substituted polycyclic ring, or together with R 3a can form an optionally substituted spiro monocyclic or spiro polycyclic C 3-i o cycloalkyl;
  • R 3b is H, optionally substituted Ci-24 alkyl, halogen, - C(0)R 21 , - OR 22 , CN, - NR 23 R 24 , NO2, -CF 3 , -S(0) X R 25 , -P(0)(0H) 2 , -0P(0)(0H) 2 , -SR 27 , optionally substituted heterocycle, optionally substituted C 3-i o cycloalkyl, optionally substituted C5-24 aryl, optionally substituted C 3- 8 cycloalkenyl, or together with R la or together with R 2a can form an optionally substituted polycyclic ring, or together with R 3 can form an optionally substituted spiro monocyclic or spiro polycyclic C 3-i o cycloalkyl;
  • R 4a is H, optionally substituted Ci-24 alkyl, halogen, - C(0)R 21 , - OR 22 , CN, - NR 23 R 24 , NO2, -CF 3 , -S(0) X R 25 , -P(0)(0H) 2 , -0P(0)(0H) 2 , -SR 27 , optionally substituted heterocycle, optionally substituted C 3-i o cycloalkyl, optionally substituted C5-24 aryl, optionally substituted C 3- 8 cycloalkenyl, or together with R la or together with R 2a can form an optionally substituted polycyclic ring, or together with R 4a can form an optionally substituted spiro monocyclic or spiro polycyclic C 3-i o cycloalkyl;
  • R 4b is H, optionally substituted Ci-24 alkyl, halogen, - C(0)R 21 , - OR 22 , CN, - NR 23 R 24 , NO2, -CF 3 , -S(0) X R 25 , -P(0)(0H) 2 , -0P(0)(0H) 2 , -SR 27 , optionally substituted heterocycle, optionally substituted C 3 -io cycloalkyl, optionally substituted C5-24 aryl, optionally substituted C 3- 8 cycloalkenyl, or together with R la or together with R 2a can form an optionally substituted polycyclic ring, or together with R 4 can form an optionally substituted spiro monocyclic or spiro polycyclic C3-10 cycloalkyl;
  • R 5 is H, optionally substituted Ci -24 alkyl, halogen- C(0)R 21 , - OR 22 , CN, - NR 23 R 24 , NO2, -CF3, -S(0) x R 25 , -P(0)(0H) 2 , -0P(0)(0H) 2 , -SR 27 , optionally substituted heterocycle, optionally substituted C3-10 cycloalkyl, optionally substituted C 5-2 4 aryl, optionally substituted C3- 8 cycloalkenyl, or together with R 6 can form an optionally substituted polycyclic ring;
  • R 6 is H, optionally substituted Ci -24 alkyl, halogen, - C(0)R 21 , - OR 22 , CN, - NR 23 R 24 , N0 2 , -CF3, -S(0) x R 25 , -P(0)(0H) 2 , -0P(0)(0H) 2 , -SR 27 , optionally substituted heterocycle, optionally substituted C3-10 cycloalkyl, optionally substituted C 5-2 4 aryl, optionally substituted C3- 8 cycloalkenyl or together with R 5 or together with R 7 can form an optionally substituted polycyclic ring;
  • R 7 is H, optionally substituted Ci -2 4 alkyl, halogen, - C(0)R 21 , - OR 22 , CN, - NR 23 R 24 , N0 2 , -CF3, -S(0) x R 25 , -P(0)(0H) 2 , -0P(0)(0H) 2 , -SR 27 , optionally substituted heterocycle, optionally substituted C3-10 cycloalkyl, optionally substituted Cs- 24 aryl, optionally substituted C3- 8 cycloalkenyl, or together with R 6 or together with R 8 can form an optionally substituted polycyclic ring;
  • R 8 is H, optionally substituted Ci -24 alkyl, halogen- C(0)R 21 , - OR 22 , CN, - NR 23 R 24 , N0 2 , -CF3, -S(0) x R 25 , -P(0)(0H) 2 , -0P(0)(0H) 2 , -SR 27 , optionally substituted heterocycle, optionally substituted C3-10 cycloalkyl, optionally substituted C 5-2 4 aryl, optionally substituted C3- 8 cycloalkenyl, or together with R 7 or together with R 9 can form an optionally substituted polycyclic ring;
  • R 9 is H, optionally substituted Ci -2 4 alkyl, halogen, - C(0)R 21 , - OR 22 , CN, - NR 23 R 24 , N0 2 , -CF3, -S(0) x R 25 , -P(0)(0H) 2 , -0P(0)(0H) 2 , -SR 27 , optionally substituted heterocycle, optionally substituted C3-10 cycloalkyl, optionally substituted C 5-2 4 aryl, optionally substituted C3- 8 cycloalkenyl, or together with R 8 can form a polycyclic ring;
  • R 21 is OH, OR 26 , NR 23 R 24 , optionally substituted Ci -2 4 alkyl, optionally substituted C3-10 cycloalkyl, optionally substituted heterocycle, optionally substituted C 5-2 4 aryl or optionally substituted C3-8 cycloalkenyl;
  • R 22 is H, optionally substituted Ci -2 4 alkyl, optionally substituted C3-10 cycloalkyl, optionally substituted heterocycle, optionally substituted C 5-2 4 aryl or optionally substituted C3-8 cycloalkenyl;
  • R 23 is H, optionally substituted Ci -24 alkyl, optionally substituted C3-10 cycloalkyl, optionally substituted heterocycle, optionally substituted C5-24 aryl or optionally substituted C3-8 cycloalkenyl;
  • R 24 is H, optionally substituted Ci -24 alkyl, optionally substituted C3-10 cycloalkyl, optionally substituted heterocycle, optionally substituted C5-24 aryl or optionally substituted C3-8 cycloalkenyl;
  • R 25 is H, optionally substituted Ci-24 alkyl, OR 22 , - NR 23 R 24 , optionally substituted heterocycle, optionally substituted C3-10 cycloalkyl, optionally substituted C5-24 aryl or optionally substituted C3-8 cycloalkenyl;
  • R 26 is optionally substituted Ci-24 alkyl, optionally substituted C3-10 cycloalkyl, optionally substituted heterocycle, optionally substituted C5-24 aryl or optionally substituted C3-8 cycloalkenyl;
  • R 27 is H, optionally substituted Ci-24 alkyl, optionally substituted C3-10 cycloalkyl, optionally substituted heterocycle, optionally substituted C5-24 aryl or optionally substituted C3-8 cycloalkenyl;
  • x 1 or 2; and with the provisos
  • R 2b is nil.
  • Table (4) Structures of Moiety (A) of the CAAC ligands
  • R 1 , R 2 , R a , R b R 3a , R 3b , R 4a , R 4b , R 5 , R 6 , R 7 , R 8 R 9 , R la , R lb , X 1 , X 2 , X, and Y are as defined herein.
  • L 1 is a N-heterocyclic carbene ligand represented by
  • R a is unsubstituted Ci-Cio alkyl, substituted Ci-Cio alkyl, unsubstituted C3-C10 cycloalkyl, substituted C 3 -C 10 cycloalkyl, unsubstituted C 5 -C 24 aryl or substituted C 5 -C 24 aryl; typically, R a is methyl, ethyl, «-propyl, .vo-propyl, «-butyl, /o/7-butyl, cyclohexyl or phenyl;
  • R b is unsubstituted C1-C10 alkyl, substituted C1-C10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C 3 -C 10 cycloalkyl, unsubstituted C 5 -C 24 aryl or substituted C 5 -C 24 aryl; typically, R b is methyl, ethyl, «-propyl, .vo-propyl, «-butyl, /o/7-butyl, cyclohexyl or phenyl; or R a and R b are linked together to form a five or a six-heterocyclic membered ring with the sulfoxide group;
  • R 3 is unsubstituted C 3- C 10 cycloalkyl, substituted C 3- C 10 cycloalkyl, unsubstituted C 5 -C 24 aryl, C 5 -C 24 aryl substituted with up to three substituents selected from unsubstituted C 1 -C 20 alkyl, substituted C 1 -C 20 alkyl, unsubstituted C 1 -C 20 heteroalkyl, substituted C 1 -C 20 hetero alkyl, unsubstituted C 5 -C 24 aryl, substituted C 5 -C 24 aryl, unsubstituted C 5 -C 24 heteroaryl, substituted C 5 -C 24 heteroaryl, unsubstituted C 6 -C 24 aralkyl, substituted C 6 -C 24 aralkyl, unsubstituted C 6 -C 24 alkaryl, substituted C 6 -C 24 alkaryl and halide; typically, R 3 is a
  • R 4 is unsubstituted C 3- C 10 cycloalkyl, substituted C 3- C 10 cycloalkyl, unsubstituted C 5 -C 24 aryl, C 5 -C 24 aryl substituted with up to three substituents selected from
  • R 4 is 2,4,6-trimethylphenyl, 2 , 6 - d i - is o -propylphcnyl, 2- mcthyl-6-/ ⁇ 2/ 7-butyl phenyl, 2 - .vo-p ropyl -6 -m
  • R 1 is hydrogen and R 2 is unsubstituted phenyl, substituted phenyl, Ci-C 6 alkyl or substituted l-propenyl; or R 1 and R 2 are linked together to form an optionally substituted indenylidene;
  • R 11 , R 12 , R 13 , and R 14 are independently Ci-C 6 alkyl, or hydrogen; generally, R 1 1 is hydrogen or methyl, R 12 is hydrogen or methyl, R 13 is hydrogen and R 14 is hydrogen; typically, R 11 , R 12 , R 13 , and R 14 are independently hydrogen; and
  • R x , R y , R w and R z are independently Ci-C 6 alkyl, hydrogen, halogen, unsubstituted phenyl or substituted phenyl; generally R x is methyl, hydrogen or Cl, R y is hydrogen, R w is hydrogen, R z is Cl, /-butyl, hydrogen or phenyl; or R x and R y are linked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl; or R w and R z are linked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl; or R y and R w are linked together to form an unsubstituted bicyclic or polycyclic aryl or a substituted bicyclic or polycyclic aryl; or R y and R w are linked together to form an unsubstituted bi
  • Non-limiting examples of olefin metathesis catalysts represented by the structure of Formula (8) are described in Table (6), wherein R a is methyl, R b is methyl, R 11 is hydrogen, R 12 is hydrogen, R 13 is hydrogen, R 14 is hydrogen, R y is hydrogen and R w is hydrogen.
  • Non-limiting examples of catalysts used in the present invention are represented by the structures:
  • L 1 is a CAAC ligand
  • R 1 , R 2 , R a , R b R 3a , R 3b , R 4a , R 4b R 5 , R 6 , R 7 , R 8 R 9 , R x , R y , R z , R w , X, Y, a and b are as defined herein.
  • R 1 , R la , R lb , R 2 , R a , R b R 3a , R 3b , R 4a , R 4b R 5 , R 6 , R 7 , R 8 R 9 , R x , R y , R z , R w , X, Y, a and b are as defined herein.
  • the Group 8 metal olefin metathesis catalysts of the invention are represented by the general structure of Formula (9)
  • M is a Group 8 transition metal; generally, M is ruthenium or osmium; typically, M is ruthenium;
  • L 1 and L 2 are independently neutral electron donor ligands
  • n is 0 or 1 ; typically, n is 0;
  • n 0, 1 or 2; generally, m is 0 or 1 ; typically, m is 0;
  • R aa is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom- containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally R aa is unsubstituted Ci-Cio alkyl, substituted Ci-Cio alkyl, unsubstituted C3-C10 cycloalkyl, substituted C 3 -C 10 cycloalkyl, unsubstituted C 5 -C 24 aryl or substituted C 5 -C 24 aryl; typically R aa is methyl, ethyl, n-propyl, /.vo-propyl, n-butyl, /er/-butyl, cyclohexyl, benzyl or phenyl;
  • R bb is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom- containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally R bb is unsubstituted C 1 -C 10 alkyl, substituted Ci-C 10 alkyl, unsubstituted C 3 -C 10 cycloalkyl, substituted C 3 -C 10 cycloalkyl, unsubstituted C 5 -C 24 aryl or substituted C 5 -C 24 aryl; typically R bb is methyl, ethyl, n-propyl, .vo-propyl, n-butyl, / ⁇ v7-butyl, cyclohexyl, benzyl or phenyl;
  • R aa and R bb can be linked to form a five-, six- or seven-membered heterocycle ring with the nitrogen atom they are linked to;
  • R cc is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom- containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally R cc is unsubstituted C 1 -C 10 alkyl, substituted Ci-C 10 alkyl, unsubstituted C 3 -C 10 cycloalkyl, substituted C 3 -C 10 cycloalkyl, unsubstituted C 5 -C 24 aryl or substituted C 5 -C 24 aryl; typically R cc is methyl, ethyl, n-propyl, /vo-propyl, n-butyl, / ⁇ v7-butyl, cyclohexyl, benzyl or phenyl;
  • R dd is unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom- containing hydrocarbyl, or substituted heteroatom-containing hydrocarbyl; generally R d is unsubstituted C1-C10 alkyl, substituted Ci-C 10 alkyl, unsubstituted C3-C10 cycloalkyl, substituted C 3 -C 10 cycloalkyl, unsubstituted C 5 -C 24 aryl or substituted C 5 -C 24 aryl; typically R dd is methyl, ethyl, n-propyl, /vo-propyl, n-butyl, tert- butyl, cyclohexyl, benzyl or phenyl;
  • R cc and R dd can be linked to form a five-, six- or seven-membered heterocycle ring with the nitrogen atom they are linked to;
  • R bb and R cc can be linked to form a five-, six- or seven-membered heterocycle ring with the nitrogen atoms they are linked to;
  • X 1 and X 2 are independently anionic ligands; generally, X 1 and X 2 are independently halogen, trifluoroacetate, per-fluorophenols or nitrate; typically, X 1 and X 2 are independently chlorine, bromine, iodine or fluorine;
  • R 1 and R 2 are independently hydrogen, unsubstituted hydrocarbyl, substituted hydrocarbyl, unsubstituted heteroatom-containing hydrocarbyl, or substituted
  • R 1 is hydrogen and R 2 is unsubstituted phenyl, substituted phenyl, Ci-C 6 alkyl or substituted 1 -propenyl; or R 1 and R 2 are linked together to form an optionally substituted indenylidene.
  • R 1 is hydrogen and R 2 is unsubstituted phenyl, substituted phenyl, Ci-C 6 alkyl or substituted 1 -propenyl; or R 1 and R 2 are linked together to form an optionally substituted indenylidene.
  • R x , R y , R w and R z are as defined herein.
  • R 5 R 6 , R 7 , R 8 , R 9 ,X 5 , Y 5 , a and b are as defined herein.
  • R 1 , R , X 1 , X 2 , R ja , R jb , R 4a , R 4b , R aa , R bb , R cc , R dd , R 5 , R 6 , R 7 , R 8 R y , X, Y, a and b are as defined herein.
  • R w , X, Y, a and b are as defined herein.
  • Moiety (A) structures selected from Table (4). For example, the structure below is assigned Formula (12A5), since Moiety (A5) is present in the CAAC ligand.
  • X, Y, a and b are as defined herein.
  • Non-limiting examples of catalysts used in the present invention are represented by the structures:
  • the ring-close metathesis macrocyclic product comprises a product internal olefin, wherein the product internal olefin is in a Z-configuration.
  • the invention provides a method that produces a compound
  • a product, olefin product e.g., ring-close metathesis product
  • a carbon-carbon double bond e.g., a product internal olefin
  • Z:E ratio greater than 95:5, greater than 96:4, greater than 97:3, greater than 98:2, or in some cases, greater than 99: 1.
  • about 100% of the carbon-carbon double bond produced in the metathesis reaction may have a Z configuration.
  • the Z or cis selectivity may also be expressed as a percentage of product formed (e.g., ring-close metathesis product).
  • the product e.g., ring-close metathesis product
  • the product may be greater than 50% Z, greater than 60% Z, greater than 70% Z, greater than 80% Z, greater than 90% Z greater than 95% Z, greater than 96% Z, greater than 97% Z, greater than about 98% Z, greater than 99% Z, or in some cases greater than 99.5% Z.
  • the ring-closing metathesis reaction product has a carbon- carbon double bond in a Z configuration and is represented by the structure of Formula (A):
  • q is 1 , 2, 3, or 4;
  • p 4, 5, 6, or 7.
  • the at least one ring-close metathesis product is represented by the structure of Formula (A), wherein q is 2 and p is 4 or 6.
  • the at least one ring-close metathesis product is represented by the structure of Formula (A), wherein q is 1, 2, 3 or 4 and p is 6 or 7.
  • the at least one ring-close metathesis product is represented by the structure of Formula (A), wherein, q is 1 or 2 and p is 6.
  • the at least one ring-close metathesis product is represented by the structure of Formula (A), wherein q is 1, 2, 3 or 4 and p is 7.
  • the at least one ring-close metathesis product is represented by the structure of Formula (A), wherein, q is 1 and p is 6.
  • the ring-closing metathesis reaction product has a carbon- carbon double bond in a Z configuration and is represented by the structure of Formula (B):
  • r is 1, 2, 3, or 4;
  • v 4, 5, 6, or 7.
  • the at least one ring-close metathesis product is represented by the structure of Formula (B), wherein r is 2 and v is 4 or 6.
  • the at least one ring-close metathesis product is represented by the structure of Formula (B), wherein r is 1 , 2, 3 or 4 and v is 6 or 7.
  • the at least one ring-close metathesis product is represented by the structure of Formula (B), wherein, r is 1 or 2 and v is 6.
  • the at least one ring-close metathesis product is represented by the structure of Formula (B), wherein r is 1, 2, 3 or 4 and v is 7.
  • the at least one ring-close metathesis product is represented by the structure of Formula (B), wherein, r is 1 and v is 6.
  • the diene starting material bearing a Z-olefin moiety can be represented by Formula (E):
  • R e is H, methyl, ethyl, or propyl
  • q 1, 2, 3, or 4;
  • p 4, 5, 6, or 7.
  • the diene starting material bearing a Z-olefin moiety can be represented by Formula (E), wherein R e is methyl, q is 2 and p is 4 or 6.
  • the diene starting material bearing a Z-olefin moiety can be represented by Formula (E), wherein R e is ethyl, q is 1, 2, 3 or 4 and p is 6 or 7.
  • the diene starting material bearing a Z-olefin moiety can be represented by Formula (E), wherein R e is ethyl, q is 1 or 2 and p is 6. [000105] In one embodiment, the diene starting material bearing a Z-olefin moiety can be represented by Formula (E), wherein R e is ethyl, q is 1, 2, 3 or 4 and p is 7.
  • the diene starting material bearing a Z-olefin moiety can be represented by Formula (E), wherein R e is ethyl, q is 1 and p is 6.
  • the invention relates to a method for performing a ring closing metathesis reaction, comprising: contacting a diene starting material bearing a Z-olefin moiety of Formula (E), with at least one olefin metathesis catalyst of Formula (5), under conditions effective to promote the formation of at least one Z-macrocycle product of Formula (A), with a Z-configuration greater than 80% Z.
  • the invention relates to a method for performing a ring closing metathesis reaction, comprising: contacting a diene starting material bearing a Z-olefin moiety of Formula (E), with at least one olefin metathesis catalyst of Formula (6), under conditions effective to promote the formation of at least one Z-macrocycle product of Formula (A), with a Z-configuration greater than 80% Z.
  • the invention relates to a method for performing a ring closing metathesis reaction, comprising: contacting a diene starting material bearing a Z-olefin moiety of Formula (E), with at least one olefin metathesis catalyst of Formula (7), under conditions effective to promote the formation of at least one Z-macrocycle product of Formula (A), with a Z-configuration greater than 80% Z.
  • the invention relates to a method for performing a ring closing metathesis reaction, comprising: contacting a diene starting material bearing a Z-olefin moiety of Formula (E), with at least one Z-stereoretentive olefin metathesis catalyst of Formula (8), under conditions effective to promote the formation of at least one Z-macrocycle product of Formula (A), with a Z-configuration greater than 80% Z.
  • the invention in another embodiment, relates to a method for performing a ring closing metathesis reaction, comprising: contacting a diene starting material bearing a Z-olefin moiety of Formula (E), with at least one Z-stereoretentive olefin metathesis catalyst of Formula (8A), under conditions effective to promote the formation of at least one Z-macrocycle product of Formula (A), with a Z-configuration greater than 80% Z.
  • the invention in another embodiment, relates to a method for performing a ring closing metathesis reaction, comprising: contacting a diene starting material bearing a Z-olefin moiety of Formula (E), with at least one Z-stereoretentive olefin metathesis catalyst of Formula
  • the invention relates to a method for performing a ring closing metathesis reaction, comprising: contacting a diene starting material bearing a Z-olefin moiety of Formula (E), with at least one Z-stereoretentive olefin metathesis catalyst of Formula
  • the invention relates to a method for performing a ring closing metathesis reaction, comprising: contacting a diene starting material bearing a Z-olefin moiety of Formula (E), with at least one Z-stereoretentive olefin metathesis catalyst of Formula (10A), under conditions effective to promote the formation of at least one Z-macrocycle product of Formula (A), with a Z-configuration greater than 80% Z.
  • the invention relates to a method for performing a ring closing metathesis reaction, comprising: contacting a diene starting material bearing a Z-olefin moiety of Formula (E), with at least one Z-stereoretentive olefin metathesis catalyst of Formula
  • the invention relates to a method for performing a ring closing metathesis reaction, comprising: contacting a diene starting material bearing a Z-olefin moiety of Formula (E), with at least one Z-stereoretentive olefin metathesis catalyst of Formula
  • the invention relates to a method for performing a ring closing metathesis reaction, comprising: contacting a diene starting material bearing a Z-olefin moiety of Formula (E), with at least one Z-stereoretentive olefin metathesis catalyst of Formula (12A), under conditions effective to promote the formation of at least one Z-macrocycle product of Formula (A), with a Z-configuration greater than 80% Z.
  • the invention provides for a method of synthesizing a musk macrocycle, represented by Formula (A), comprising, a ring closing metathesis reaction on a diene of Formula (E), in the presence of at least one metathesis catalyst under conditions sufficient to form a metathesis product, wherein the at least one metathesis catalyst is represented by the structure of Formula (5), and wherein R e , q, p, R 1 , R 2 , R a , R b , X 1 , X 2 , R 3 and R 4 are as defined herein.
  • the invention provides for a method of synthesizing a musk macrocycle, represented by Formula (A), comprising, a ring closing metathesis reaction on a diene of Formula (E), in the presence of at least one metathesis catalyst under conditions sufficient to form a metathesis product, wherein the at least one metathesis catalyst is represented by the structure of Formula (8), and wherein R e , q, p, R 1 , R 2 , R a , R b , R 11 , R 12 , R 13 , R 14 , R 3 , R 4 , R x , R y , R z and R w are as defined herein.
  • R a is methyl
  • R b is methyl
  • R 11 is hydrogen
  • R 12 is hydrogen
  • R 13 is hydrogen
  • R 14 is hydrogen
  • R 3 is 2,4,6-trimethylphenyl
  • 2 , 6 - d i - is -propylphcnyl, 2-methyl-6- / ⁇ v7-butylphcnyl, 2-/.v -propyl-6-mcthyl phenyl
  • 2- is o - p ro p yl - p h c n yl , 2,6-di-ethylphenyl, 2-ethyl- 6-methylphenyl, 2,4,6-trifluorophenyl, 2,6-difluorophenyl, 3, 5-di-/ ⁇ v7-butyl phenyl, 2,4- dimethylphenyl or 2-methyl-phenyl
  • R 4 is 2,4,6-trimethylphenyl
  • the invention provides for a method of synthesizing a musk macrocycle of Formula (A) comprising, performing a ring closing metathesis reaction on a diene of Formula (E) wherein R e is H, methyl, ethyl, or propyl; q is 1, 2, 3, or 4; p is 4, 5, 6, or 7; in the presence of at least one metathesis catalyst under conditions sufficient to form a metathesis product, wherein the at least one metathesis catalyst is represented by the structure of Formula (5), wherein the catalyst is selected from: C591, C731, C625, C763, C663, C641, C647m, C747, C647, C676, C773, C673, C651 and C83lm.
  • the invention provides for a method of synthesizing a musk macrocycle of Formula (A) comprising, performing a ring closing metathesis reaction on a diene of Formula (E) wherein R e is H, methyl, ethyl, or propyl; q is 1, 2, 3, or 4; p is 4, 5, 6, or 7; in the presence of at least one metathesis catalyst under conditions sufficient to form a metathesis product, wherein the at least one metathesis catalyst is represented by the structure of Formula (8), wherein the catalyst is selected from: C885ss, C785ss, C738ss, C869ss, and C725ss.
  • the invention provides for a method of synthesizing a musk macrocycle of Formula (B) comprising, performing a ring closing metathesis reaction on a diene of Formula (E) wherein R e is H, methyl, ethyl, or propyl; r is 1, 2, 3, or 4; v is 4, 5, 6, or 7; in the presence of at least one metathesis catalyst under conditions sufficient to form a metathesis product, wherein the at least one metathesis catalyst is represented by the structure of Formula (12), wherein the catalyst is selected from: O801tu, O701tu, C885TU, C88 ln , C799TU, 0951tu and C799UTU-
  • the diene starting material bearing a Z-olefin moiety can be represented by Formula (F):
  • R f is H, methyl, ethyl, or propyl
  • r is 1, 2, 3, or 4;
  • v 4, 5, 6, or 7.
  • the diene starting material bearing a Z-olefin moiety can be represented by Formula (F), wherein R f is methyl, r is 2 and v is 4 or 6.
  • the diene starting material bearing a Z-olefin moiety can be represented by Formula (F), wherein R f is ethyl, r is 1, 2, 3 or 4 and v is 6 or 7.
  • the diene starting material bearing a Z-olefin moiety can be represented by Formula (F), wherein R f is ethyl, r is 1 or 2 and v is 6.
  • the diene starting material bearing a Z-olefin moiety can be represented by Formula (F), wherein R f is ethyl, r is 1, 2, 3 or 4 and v is 7.
  • the diene starting material bearing a Z-olefin moiety can be represented by Formula (F), wherein R f is ethyl, r is 1 and v is 6.
  • the invention provides for a method of synthesizing a musk macrocycle of Formula (B) comprising, performing a ring closing metathesis reaction on a diene of Formula (F) wherein R f is H, methyl, ethyl, or propyl; r is 1, 2, 3, or 4; v is 4, 5, 6, or 7; in the presence of at least one metathesis catalyst under conditions sufficient to form a metathesis product, wherein the at least one metathesis catalyst is represented by the structure of Formula (5), wherein the catalyst is selected from: C591 , C731, C625, C763, C663, C641, C647m, C747, C647, C676, C773, C673, C651 and C83lm.
  • the invention provides for a method of synthesizing a musk macrocycle of Formula (B) comprising, performing a ring closing metathesis reaction on a diene of Formula (F) wherein R f is H, methyl, ethyl, or propyl; r is 1, 2, 3, or 4; v is 4, 5, 6, or 7; in the presence of at least one metathesis catalyst under conditions sufficient to form a metathesis product, wherein the at least one metathesis catalyst is represented by the structure of Formula (8), wherein the catalyst is selected from: C885ss, C785ss, C738ss, C869ss, and C725ss.
  • the invention provides for a method for synthesizing a musk macrocycle, represented by Formula
  • R lm is H or methyl
  • OR 2m is a protected hydroxyl group, which may be selected from an alkyl ether group; an ester group; a silyl ether group; or a carbonate group
  • R 3m is branched or straight C 1 -C 5 alkyl
  • x is 2, 3, 4 or 5
  • y is 5, 6, 7, or 8.
  • the invention provides for a method for synthesizing a musk macrocycle, represented by Formula (K)
  • R lm is H or methyl
  • OR 2m is a protected hydroxyl group, which may be selected from an alkyl ether group; an ester group; a silyl ether group; or a carbonate group
  • R 3m is branched or straight C1-C5 alkyl
  • x is 2, 3, 4 or 5
  • y is 5, 6, 7, or 8.
  • first and second olefins may be olefins with a terminal double bond.
  • one of the first or second olefin may be represented by the Formula (G), wherein: R lm is H or methyl; OR 2m is a protected hydroxyl group, which may be selected from an alkyl ether group; an ester group; a silyl ether group; or a carbonate group; and x is 2, 3, 4 or 5.
  • R lm is H or methyl
  • OR 2m is a protected hydroxyl group, which may be selected from an alkyl ether group; an ester group; a silyl ether group; or a carbonate group
  • x is 2, 3, 4 or 5.
  • one of the first or second olefin may be represented by the Formula (H), wherein: R 3m is branched or straight C1-C5 alkyl; and y is 5, 6, 7, or 8.
  • the intermediate formed during the cross metathesis reaction between the first olefin of Formula (G), and the second olefin, of Formula (H), in the presence of at least one ruthenium olefin metathesis catalyst can be represented by the Formula (J), wherein: R lm is H or methyl; OR 2m is a protected hydroxyl group, which may be selected from an alkyl ether group, an ester group, a silyl ether group and a carbonate group; R 3m is branched or straight C1-C5 alkyl; x is 2, 3, 4 or 5; R 3m is branched or straight C1-C5 alkyl; and y is 5, 6, 7, or 8.
  • the intermediate of Formula (J) can be formed in the presence of any of the ruthenium metathesis catalysts represented by Formula (1), Formula (2), Formula (3), Formula (4), Formula (5), Formula (6), Formula (7), Formula (8), Formula (8 A), Formula (9), Formula (10), Formula (10A), Formula (11), Formula (12), Formula (12A) or Formula (13).
  • the ruthenium catalyst can be selected from any of the structures defined, represented or exemplified herein.
  • Common macrocyclic musk compounds include ambrettolide (9-ambrettolide and 7 -ambrettolide), nirvanolide, habanolide, cosmone, muscenone, velvione, civetone and globanone.
  • the first and second olefin compounds that can be used to form 7 - ambretolide may be selected from lO-(tert-butoxy)dec-l -ene and methyl oct-7-enoate or dec-9- en-l -yl acetate and methyl oct-7 -enoate.
  • the first and second olefin compounds that can be used to form Habanolide may be selected from trimethyl (pent-4-en-l -yloxy)silane and ethyl dodec- 11 -enoate.
  • the first and second olefin compounds that can be used to form Nirvanolide may be selected from 4-methyl-6-(tert-butoxy)hex-l-ene and methyl 9-decenoate, or 4-methy l-6-( tert- butoxy )hex -l-ene and ethyl-9-decenoate, or 3-methylhex-5-en-l-yl propionate and methyl 9- decenoate.
  • the method of the present invention whereby a hetero-dimer is first formed by metathesis, and then ring-closed by a macrocyclization step, represents a considerably simpler and cheaper process than RCM to form macrocyclic musk compounds, which is industrially scalable in an economic manner.
  • macrocyclic derivatives obtained via the methods of the invention can be used in the fragrance and flavor industry.
  • the macrocyclic derivatives include, for example, the compounds listed in Table (11).
  • Exemplary embodiments provided in accordance with the presently disclosed subject matter include, but are not limited to, the claims and the following embodiments.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Fats And Perfumes (AREA)
  • Pyrane Compounds (AREA)
EP19705159.2A 2018-02-13 2019-02-11 Reaktionen von olefinderivaten in gegenwart von metathesekatalysatoren Withdrawn EP3752494A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862629857P 2018-02-13 2018-02-13
PCT/EP2019/053336 WO2019158485A1 (en) 2018-02-13 2019-02-11 Reactions of olefin derivatives in the presence of metathesis catalysts

Publications (1)

Publication Number Publication Date
EP3752494A1 true EP3752494A1 (de) 2020-12-23

Family

ID=65411874

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19705159.2A Withdrawn EP3752494A1 (de) 2018-02-13 2019-02-11 Reaktionen von olefinderivaten in gegenwart von metathesekatalysatoren

Country Status (6)

Country Link
US (2) US11161104B2 (de)
EP (1) EP3752494A1 (de)
JP (1) JP7343529B2 (de)
CN (1) CN111788189A (de)
BR (1) BR112020016342A2 (de)
WO (1) WO2019158485A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019158485A1 (en) * 2018-02-13 2019-08-22 Umicore Ag & Co. Kg Reactions of olefin derivatives in the presence of metathesis catalysts
WO2020109217A2 (en) * 2018-11-29 2020-06-04 Umicore Ag & Co. Kg Metal organic compounds

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018208501A1 (en) * 2017-05-08 2018-11-15 California Institute Of Technology A highly efficient synthesis of z-macrocycles using stereoretentive, ruthenium-based metathesis catalysts

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7039565B1 (en) * 2003-01-03 2006-05-02 Haestad Methods, Inc. Method and system for developing a numerical dynamic sanitary sewer and storm water drainage simulation model
US8501973B2 (en) * 2006-10-13 2013-08-06 Elevance Renewable Sciences, Inc. Synthesis of terminal alkenes from internal alkenes via olefin metathesis
DE102010040822B4 (de) * 2010-09-15 2013-09-12 Ernst-Moritz-Arndt-Universität Neue Imidazoliumsalze und darauf basierende Carben-Metallkomplexe zur Verwendung als bioanalytische Marker für Biomoleküle
US9150468B2 (en) * 2011-09-28 2015-10-06 Nalco Company Method of producing olefins via metathesis
WO2014201300A1 (en) * 2013-06-12 2014-12-18 Trustees Of Boston College Catalysts for efficient z-selective metathesis
GB201404468D0 (en) * 2014-03-13 2014-04-30 Givaudan Sa Process
EP3115368A1 (de) 2015-07-10 2017-01-11 Bergen Teknologioverforing AS Verbesserte olefinmetathesekatalysatoren
US10857530B2 (en) * 2015-12-10 2020-12-08 Umicore Ag & Co. Kg Olefin metathesis catalysts
HUE061150T2 (hu) * 2016-08-24 2023-05-28 Umicore Ag & Co Kg Metatéziskatalizátorok szintézise és jellemzése
WO2018191373A1 (en) 2017-04-12 2018-10-18 Materia, Inc. Synthesis and characterization of metathesis catalysts
WO2019158485A1 (en) * 2018-02-13 2019-08-22 Umicore Ag & Co. Kg Reactions of olefin derivatives in the presence of metathesis catalysts

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018208501A1 (en) * 2017-05-08 2018-11-15 California Institute Of Technology A highly efficient synthesis of z-macrocycles using stereoretentive, ruthenium-based metathesis catalysts

Also Published As

Publication number Publication date
US11958042B2 (en) 2024-04-16
CN111788189A (zh) 2020-10-16
JP2021513572A (ja) 2021-05-27
US11161104B2 (en) 2021-11-02
US20220055025A1 (en) 2022-02-24
JP7343529B2 (ja) 2023-09-12
BR112020016342A2 (pt) 2020-12-15
WO2019158485A1 (en) 2019-08-22
US20210046466A1 (en) 2021-02-18

Similar Documents

Publication Publication Date Title
US6613910B2 (en) One-pot synthesis of group 8 transition metal carbene complexes useful as olefin metathesis catalysts
CA2824518C (en) Z-selective olefin metathesis catalysts and their synthetic procedure
US9403854B2 (en) Cross-metathesis reaction of functionalized and substituted olefins using group 8 transition metal carbene complexes as metathesis catalysts
US20030236367A1 (en) Ring-expansion of cyclic olefins by olefin metathesis reactions with an acyclic diene
EP3386936B1 (de) Olefinmetathesekatalysatoren
US8501975B2 (en) Method for manufacturing ruthenium carbene complexes
JP2007530706A (ja) Ｎ−複素環カルベンリガンドを含有する高活性潜伏オレフィン複分解触媒
WO2013134192A1 (en) Syntheses of z-olefin-containing lepidopteran insect pheromones
US11958042B2 (en) Reactions of olefin derivatives in the presence of metathesis catalysts
EP3496855B1 (de) Metathesekatalysatoren
McGonagle et al. A three-step tandem process for the synthesis of bicyclic γ-lactams
US9586981B2 (en) Z-selective metathesis catalysts
RU2375379C1 (ru) Катализатор метатезисной полимеризации дициклопентадиена, способ его получения (варианты) и способ его полимеризации
US11053209B2 (en) Highly efficient synthesis of z-macrocycles using stereoretentive, ruthenium-based metathesis catalysts
KR20210008531A (ko) 입체유지적 복분해에 의한 프로스타글란딘 j 천연 생성물의 전합성
US11407726B2 (en) Using stereoretention for the stereoselective formation of e-macrocycles with Ru-based olefin metathesis catalysts
KR20140054030A (ko) 시클로헵텐의 제조 방법
WO2016014954A1 (en) Tandem z-selective metathesis / dihydroxylation
JP2023152776A (ja) オレフィン化合物の製造方法
RU2574718C1 (ru) Катализатор метатезисной полимеризации дициклопентадиена, содержащий ацетамидный фрагмент, и способ его получения
Schneider et al. Substituted Macrolactones via Oligomerisation of α-Bromomethylacrylic Acid Derivatives
RU2330015C1 (ru) СПОСОБ ПОЛУЧЕНИЯ ЭФИРОВ БИС-α, β-НЕНАСЫЩЕННЫХ ДИКАРБОНОВЫХ КИСЛОТ

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20200914

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

TPAC Observations filed by third parties

Free format text: ORIGINAL CODE: EPIDOSNTIPA

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

TPAC Observations filed by third parties

Free format text: ORIGINAL CODE: EPIDOSNTIPA

17Q First examination report despatched

Effective date: 20210614

TPAC Observations filed by third parties

Free format text: ORIGINAL CODE: EPIDOSNTIPA

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20211211